Discover the complete record of transactions filed by Yan Ming, Chief Technology Officer. Officer active across 1 companies, notably Cytek Biosciences, Inc.. Aggregated, 7 reports have been published. Total volume traded: €1m. The latest transaction was disclosed on 21 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Yan Ming is the Chief Technology Officer of Cytek Biosciences, Inc. In this role, he oversees technological development and innovation within the company. His technical expertise is essential to ensure that Cytek Biosciences, Inc. remains at the forefront of innovation in the life sciences sector.